Michael J. Brunelle
Direttore/Membro del Consiglio presso OncoPlex Diagnostics, Inc.
Profilo
Michael J.
Brunelle is currently a Director at OncoPlex Diagnostics, Inc., Diagnostic ID LLC, and DiThera, Inc. He previously held positions as Senior Director-Integration at American Bioscience, Inc., Non-Independent Director at Liminal BioSciences, Inc., Director at Theranostix, Inc. (Indiana), Director at Exploration Aurtois, Inc., Vice President-Acquisitions & Development at Abraxis BioScience, Inc., Vice President at Dillon, Read & Co., Inc., Assistant Hospital Administrator at American Medical International, Inc., President at Pharm Plus Resources, Inc., and Vice President-Development at NantWorks LLC.
Brunelle holds an MBA from the University of Pennsylvania and an undergraduate degree from the University of California San Diego.
Posizioni attive di Michael J. Brunelle
| Società | Posizione | Inizio |
|---|---|---|
OncoPlex Diagnostics, Inc.
 OncoPlex Diagnostics, Inc. Medical/Nursing ServicesHealth Services OncoPlex Diagnostics, Inc. operates a cancer diagnostics laboratory. It provides information that helps physicians choose targeted therapies and avoid therapies. The company is headquartered in Rockville, MD. | Direttore/Membro del Consiglio | - |
| DiThera, Inc. | Direttore/Membro del Consiglio | - |
| Diagnostic ID LLC | Direttore/Membro del Consiglio | - |
Precedenti posizioni note di Michael J. Brunelle
| Società | Posizione | Fine |
|---|---|---|
| LIMINAL BIOSCIENCES INC. | Direttore/Membro del Consiglio | 13/11/2013 |
Abraxis BioScience, Inc.
 Abraxis BioScience, Inc. Pharmaceuticals: MajorHealth Technology Abraxis Bioscience, Inc. develops therapeutics for cancer, infectious diseases and other critical illnesses. Its development platform uses nanoparticle albumin-bound technology to deliver drugs to tumors that produce SPARC. Abraxene, the first protein-based nanoparticle chemotherapeutic compound, is FDA approved for treating metastatic breast cancer. Abraxis Bioscience is focused on expanding the use of Abraxene and developing other drug candidates utilizing the same technology. Abraxene is approved for marketing in over 35 countris and the company has manufacturing facilities in the United States and Switzerland. Abraxis Bioscience was organized in 2007 from the oncology and research businesses of American Pharmaceutical Partners, Inc. and is headquartered in Los Angeles, CA. | Corporate Officer/Principal | 30/03/2011 |
Exploration Aurtois, Inc.
 Exploration Aurtois, Inc. Precious MetalsNon-Energy Minerals Exploration Aurtois, Inc. engages in the provision of mineral exploration and development. The firm focuses on gold and other mineral deposits. The company was founded on February 3, 2005 and is headquartered in Belleterre, Canada. | Direttore/Membro del Consiglio | 22/11/2010 |
Abraxis BioScience, Inc. /Old/
 Abraxis BioScience, Inc. /Old/ Pharmaceuticals: MajorHealth Technology Abraxis BioScience, Inc. manufactures specialty pharmaceutical products. The company develops, manufactures and markets injectable products and leverages revolutionary technology such as its nab(TM) platform to discover and deliver breakthrough therapeutics that transform the treatment of cancer and other life threatening diseases. The company is located in Schaumburg, IL | Corporate Officer/Principal | 01/11/2007 |
Pharm Plus Resources, Inc.
 Pharm Plus Resources, Inc. Drugstore ChainsRetail Trade Part of CVS Health Corp., Pharm Plus Resources, Inc. is a company that provides pharmaceutical delivery and reimbursement services. The company is based in Van Nuys, CA. Pharm Plus Resources was acquired by US Bioservices Corp., part of CVS Health Corp. from January 17, 2003 on September 16, 2002. | Presidente | 01/01/2002 |
Formazione di Michael J. Brunelle
| University of California San Diego | Undergraduate Degree |
| University of Pennsylvania | Masters Business Admin |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Società quotate in Borsa | 1 |
|---|---|
| LIMINAL BIOSCIENCES INC. | Health Technology |
| Aziende private | 12 |
|---|---|
Abraxis BioScience, Inc.
Abraxis BioScience, Inc. Pharmaceuticals: MajorHealth Technology Abraxis Bioscience, Inc. develops therapeutics for cancer, infectious diseases and other critical illnesses. Its development platform uses nanoparticle albumin-bound technology to deliver drugs to tumors that produce SPARC. Abraxene, the first protein-based nanoparticle chemotherapeutic compound, is FDA approved for treating metastatic breast cancer. Abraxis Bioscience is focused on expanding the use of Abraxene and developing other drug candidates utilizing the same technology. Abraxene is approved for marketing in over 35 countris and the company has manufacturing facilities in the United States and Switzerland. Abraxis Bioscience was organized in 2007 from the oncology and research businesses of American Pharmaceutical Partners, Inc. and is headquartered in Los Angeles, CA. | Health Technology |
Abraxis BioScience, Inc. /Old/
Abraxis BioScience, Inc. /Old/ Pharmaceuticals: MajorHealth Technology Abraxis BioScience, Inc. manufactures specialty pharmaceutical products. The company develops, manufactures and markets injectable products and leverages revolutionary technology such as its nab(TM) platform to discover and deliver breakthrough therapeutics that transform the treatment of cancer and other life threatening diseases. The company is located in Schaumburg, IL | Health Technology |
Pharm Plus Resources, Inc.
Pharm Plus Resources, Inc. Drugstore ChainsRetail Trade Part of CVS Health Corp., Pharm Plus Resources, Inc. is a company that provides pharmaceutical delivery and reimbursement services. The company is based in Van Nuys, CA. Pharm Plus Resources was acquired by US Bioservices Corp., part of CVS Health Corp. from January 17, 2003 on September 16, 2002. | Retail Trade |
| Dillon, Read & Co., Inc. | Finance |
American Medical International, Inc.
 American Medical International, Inc. Hospital/Nursing ManagementHealth Services American Medical International, Inc. develops and operates integrated health care delivery systems by offering health care services and medical benefit programs. The company is now known as Tenet Healthcare Corporation | Health Services |
| American Bioscience, Inc. | Health Technology |
Exploration Aurtois, Inc.
Exploration Aurtois, Inc. Precious MetalsNon-Energy Minerals Exploration Aurtois, Inc. engages in the provision of mineral exploration and development. The firm focuses on gold and other mineral deposits. The company was founded on February 3, 2005 and is headquartered in Belleterre, Canada. | Non-Energy Minerals |
NantWorks LLC
 NantWorks LLC Information Technology ServicesTechnology Services NantWorks LLC develops technology based semiconductor and advanced networks for healthcare improvements. Its solution is for life threatening diseases such as cancer, infectious diseases and Alzheimer’s. The company was founded by Patrick Soon-Shiong in September 2011 and is headquartered in Culver City, CA. | Technology Services |
Theranostix, Inc. (Indiana)
 Theranostix, Inc. (Indiana) Miscellaneous Commercial ServicesCommercial Services Theranostix, Inc. engages in the development and market of medical deoxyribonucleic acid (DNA) testing product. It offers know error system, and UroSeq. The company was founded by Peter M. Knapp and is headquartered in Indianapolis, IN. | Commercial Services |
OncoPlex Diagnostics, Inc.
OncoPlex Diagnostics, Inc. Medical/Nursing ServicesHealth Services OncoPlex Diagnostics, Inc. operates a cancer diagnostics laboratory. It provides information that helps physicians choose targeted therapies and avoid therapies. The company is headquartered in Rockville, MD. | Health Services |
| DiThera, Inc. | |
| Diagnostic ID LLC |
- Borsa valori
- Insiders
- Michael J. Brunelle
